4
Clinical Trials associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)一项评价CG-BM1异体人骨髓间充质干细胞注射液治疗缺血性脑卒中安全性和有效性的临床试验
[Translation] A clinical trial to evaluate the safety and efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of ischemic stroke
评价CG-BM1治疗缺血性脑卒中患者的安全性和耐受性,确定临床用药的安全范围。
[Translation] To evaluate the safety and tolerability of CG-BM1 in the treatment of patients with ischemic stroke and determine the safe range of clinical use.
一项评价CG-BM1异体人骨髓间充质干细胞注射液治疗慢加急性肝衰竭患者的安全性、耐受性和初步有效性临床试验
[Translation] A clinical trial to evaluate the safety, tolerability and preliminary efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of patients with acute-on-chronic liver failure
主要目的:评价CG-BM1多次给药治疗成人ACLF患者的有效性。次要目的:评价CG-BM1多次给药治疗成人ACLF患者的安全性。
[Translation] Primary objective: To evaluate the efficacy of multiple administrations of CG-BM1 in the treatment of adult patients with ACLF. Secondary objective: To evaluate the safety of multiple administrations of CG-BM1 in the treatment of adult patients with ACLF.
一项评价CG-BM1异体人骨髓间充质干细胞注射液治疗慢加急性肝衰竭患者的安全性、耐受性和初步有效性临床试验
[Translation] A clinical trial to evaluate the safety, tolerability and preliminary efficacy of CG-BM1 allogeneic human bone marrow mesenchymal stem cell injection in the treatment of patients with acute-on-chronic liver failure
主要目的:评价CG-BM1治疗成人ACLF患者的安全性和耐受性,确定临床用药的安全范围。次要目的:观察CG-BM1治疗成人ACLF患者的初步有效性,为后续临床试验方案设计提供依据。
[Translation] Primary purpose: To evaluate the safety and tolerability of CG-BM1 in the treatment of adult ACLF patients and determine the safety range of clinical medication. Secondary purpose: To observe the preliminary efficacy of CG-BM1 in the treatment of adult ACLF patients and provide a basis for the design of subsequent clinical trial programs.
100 Clinical Results associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Translational Medicine associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Patents (Medical) associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)
100 Deals associated with CG-BM1 Allogenic Bone marrow derived MSC (Guangzhou Cellgenes)